40 billion CFU probiotic: is more actually better?

The number on the front of a probiotic bottle has gone from 5 billion CFU in the early 2000s, to 10 billion, to 50 billion, to 100 billion, to bottles now advertising 200 billion or more. The marketing reads like an arms race. Bigger is better, the logic goes; more bacteria reaching the gut means more benefit. The customer pays the higher price and assumes the relationship is linear.

It isn't. The CFU-to-benefit relationship in probiotic research isn't linear. It's a curve that rises sharply at the start, flattens through a moderate range, and stays mostly flat above a certain threshold. The threshold for most well-studied strains is well below the 100-billion mark. Above that, you're paying a premium for marginal returns, often on a formula that hasn't actually been tested at the higher dose.

This is the CFU question. What's the dose your gut actually responds to, and why does the research keep pointing at a number that's smaller than the front-of-pack number on most premium bottles?

What CFU actually means

CFU stands for colony-forming units, which is the lab measure of how many viable bacteria are in a dose at the moment of measurement. It's a count of live organisms, not total weight. One CFU equals roughly one bacterium capable of dividing.

The number matters because probiotics are alive. Dead bacteria don't colonise the gut, don't ferment fibre into the short-chain fatty acids that produce most of the downstream effects, and don't do the work the studies measured. CFU at the moment you swallow the capsule is the practical dose.

The complication is when the CFU is measured. A "100 billion CFU" formula could be measured at the moment of manufacture, when the strains were freshest, or at the end of shelf life, by which point a meaningful fraction has died off. The same number can mean very different practical doses depending on which point the manufacturer chose. The label that lists CFU at expiry is the one telling you the truth about what reaches you.

The dose-response curve in actual research

The clinical research on probiotics has tested doses across a wide range, from 1 billion CFU at the low end to 450 billion CFU in a few specialised formulations. The pattern across this range is clear and underused in marketing.

Below about 5 to 10 billion CFU per day, results in most outcomes (digestion stabilisation, immune markers, mood, skin) are inconsistent. Some studies show effects, some don't, and it's hard to tell whether you're under-dosing or whether the strain is wrong. The 5-billion floor is roughly where research effects start to land reliably.

Between about 10 and 50 billion CFU per day, the dose-response curve rises. More live bacteria reach the gut, the effects on the measured outcomes get larger, and the consistency across studies improves. This range is where the bulk of well-designed probiotic studies have been run.

Above about 50 billion CFU, the curve flattens. Doubling the dose to 100 billion produces a small additional improvement in some outcomes, no detectable improvement in others, and inconsistent results across studies. By 200 billion, most researchers consider the marginal benefit too small to justify the cost increase. There are exceptions for specific medical conditions (the high-dose VSL #3 protocol for ulcerative colitis is one), but those are clinical interventions, not daily-wellness supplementation.

The 40-to-50 billion range sits in the sweet spot. Above the noise floor, into the part of the curve where research effects are reliable, below the diminishing-returns inflection. KAEVO Flora 40 was named for exactly this number for exactly this reason.

Why 40 billion outperforms 100 billion in practice

This is the part that contradicts the marketing intuition. A 40-billion CFU formula taken consistently for 90 days delivers about 3.6 trillion live organisms to the gut over the period. A 100-billion CFU formula taken for 30 days and then forgotten delivers about 3 trillion. The lower-dose, longer-window protocol delivers more total live bacteria.

That math matters because probiotic colonisation is mostly transient. Strains pass through, exert effects while they're present, and don't permanently take up residence in most cases. The thing that produces a stable shift in the gut environment is the daily presence of beneficial bacteria over weeks, not a heroic dose followed by a gap. A 40-billion-CFU daily formula is a routine. A 100-billion-CFU mega-dose is an event.

There's also a strain-quality argument. A 100-billion CFU formula often achieves the count by stuffing in many strains, some of which lack research support. A 40-billion CFU formula in the research-backed range can afford to be more selective about which strains it includes, prioritising ones with peer-reviewed evidence over ones that just bulk up the number. Reading the strain list (with their identifier letters and numbers, like Lactobacillus rhamnosus GG or Bifidobacterium lactis BB-12) tells you whether the formula is using research-grade strains or anonymous ones.

What about strain count

Closely related question: does a 10-strain formula beat a 4-strain formula? The honest answer is "it depends on which strains." More isn't automatically better here either. Some of the most-studied probiotic effects come from formulas with two or three specific strains chosen for synergy. Throwing eight more in doesn't necessarily add benefit, and may dilute the effective dose of the well-studied ones.

A reasonable formula will list each strain by name and identifier, give you the CFU per strain (not just the total), and stick to combinations that have been tested together. If the label says "proprietary blend" without breaking down the strains, you're being asked to trust the manufacturer rather than read the dose. Modern, transparent formulas don't do that anymore.

The synbiotic question

The other thing worth knowing is whether the probiotic includes a prebiotic. A probiotic delivers bacteria. A prebiotic is the fibre those bacteria eat. A synbiotic is both in the same formula. The research generally favours synbiotic formulations over probiotic-alone ones, because bacteria delivered without their food source produce less consistent effects.

Common prebiotic fibres include inulin, fructooligosaccharides (FOS), and partially hydrolyzed guar fibre. The amount in a synbiotic capsule is small (usually 50 to 200 mg) but enough to support the strains during the first hours after dosing. This is a meaningful spec to look for. Flora 40 is a synbiotic for this reason; the prebiotic fibre included gives the strains something to feed on rather than dropping them into the gut hungry.

What about food sources

The other reasonable question: can yogurt, kefir, kombucha, and fermented foods replace a probiotic supplement? Partly, with caveats.

Live-culture yogurt typically contains 1 to 10 billion CFU per serving, mostly Lactobacillus bulgaricus and Streptococcus thermophilus. These are real probiotic strains and they do real work. The complication is that those two strains are mostly transient passengers, not the strains best-studied for the broader gut effects, and the CFU varies wildly between brands (some commercial yogurts have been found to contain almost no live cultures by expiry).

Kefir is denser, often 10 to 30 billion CFU per cup, with more strain diversity than yogurt. It's the strongest food-source probiotic in terms of dose. Kombucha has lower CFU counts and the strains are different (mostly Acetobacter and yeast, similar to ACV) so the effects are different. Sauerkraut, kimchi, and other fermented vegetables contribute meaningfully if you eat them often, less meaningfully if you eat them once a month.

The honest answer is that a daily yogurt-or-kefir habit can do a meaningful fraction of what a daily probiotic supplement does, especially for general gut maintenance. A daily probiotic supplement adds strain consistency, dose precision, and shelf-stable convenience that food alone can't provide. The two aren't competitors; the strongest gut routines often include both.

Choosing strains, not just CFU

Beyond the count, the strains matter. The supplement industry has been slow to communicate this clearly, but the research does distinguish between strains in meaningful ways. Lactobacillus rhamnosus GG has the most evidence for general gut and immune effects. Bifidobacterium lactis BB-12 is well-studied for stool consistency and travel-related gut disruption. Lactobacillus acidophilus has older but solid evidence across multiple outcomes. Saccharomyces boulardii (a yeast, not a bacterium) has specific evidence for antibiotic-associated and traveler's gut.

A formula that names its strains down to the identifier (the letters and numbers after the species name) is being transparent about what's actually in it. A formula that lists "Lactobacillus acidophilus" without an identifier could be using a research-grade strain or a generic lab strain with no specific evidence; you have no way to tell.

The practical advice for non-specialists: prioritise formulas that name specific strains with identifiers, that include the well-studied ones above, and that don't bury 12 anonymous strains inside a "proprietary blend." Strain quality is a meaningful differentiator. Most consumers can't read all the literature, but they can recognise transparency on the label.

Putting the routine together

If you're starting a probiotic next week, the routine is short. Pick a formula in the 30 to 50 billion CFU range. Confirm the CFU is measured at expiry, not at manufacture. Confirm each strain is named and quantified, not hidden in a proprietary blend. Make sure there's at least one prebiotic fibre included to make it a true synbiotic. Take it daily, with breakfast, for 90 days before deciding whether it's earning its place.

If you'd rather not vet labels at that level of detail, KAEVO Flora 40 is built around exactly this profile. 40 billion CFU at expiry, named strains, prebiotic fibre included, shelf-stable so you don't have to fight your fridge. The Gut Reset bundle pairs Flora 40 with KAEVO Reset (the apple-cider-vinegar baseline) for the full daily gut routine. The bundle quiz sorts the rest of the sequencing in about a minute.

For a deeper dive on probiotic timing specifically, the best time to take a probiotic post covers when in the day the dose actually survives.

Delivery and shelf-stability matter too

Two final label specs worth noticing: the capsule technology and the storage requirement. Some formulas use delayed-release or enteric-coated capsules that bypass stomach acid and dissolve further down the digestive tract, which can dramatically improve survival rates for the strains. Others use simpler capsules that rely on the formula's inherent acid resistance.

For lactic acid bacteria specifically, delayed-release helps. For spore-based formulas, the spore coating already does the job and the capsule is just a delivery mechanism. The label rarely advertises "delayed-release" prominently; you usually have to look at the capsule description in the supplement facts panel.

The shelf-stability angle: refrigerated formulas tend to maintain CFU better over their shelf life, but they require fridge space and they're vulnerable to room-temperature exposure during shipping or travel. Modern shelf-stable formulas use strain selection and packaging (desiccant pouches, blister packs) to preserve viability without the fridge requirement, which makes them dramatically more convenient for daily routines and travel.

What about taking it during antibiotics

A specific scenario worth covering: should you take a probiotic during a course of antibiotics? Yes, with timing care. The antibiotic doesn't distinguish between the bacteria you want to keep and the ones it's there to kill, so any probiotic taken simultaneously gets blown out. The standard advice is to space the probiotic two to three hours after the antibiotic dose, take it daily for the duration of the course, and continue for at least two to four weeks after the course ends. The post-course window is when the gut is rebuilding and the daily flux of beneficial bacteria does most of its work.

The strain that has the most evidence for antibiotic-associated effects is Saccharomyces boulardii, a probiotic yeast that's not affected by antibacterial antibiotics at all. A short course of S. boulardii alongside a regular probiotic is the most evidence-supported version of "what to take during antibiotics." For most people without specific complications, the regular daily probiotic spaced from the antibiotic dose is enough.

The short version

The dose-response curve for probiotics flattens above about 50 billion CFU. The 40-billion daily range sits in the sweet spot above the noise floor and below the diminishing-returns inflection. A 40-billion formula taken consistently for 90 days delivers more total bacteria than a 100-billion mega-dose taken sporadically. The CFU arms race is marketing, not biology. Read the label for strain transparency, expiry-date CFU, and a prebiotic fibre. Take it daily. The boring answer is the right one.